Brief: Novo Holdings Dissolves Share Stake In Recursion Pharmaceuticals
17/02/2026 21:52
Feb 17 (Reuters) - Novo Holdings A/S: DISSOLVES SHARE STAKE IN RECURSION PHARMACEUTICALS - SEC FILING CHANGE IN HOLDINGS ARE AS OF DEC 31, 2025 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF SEPT. 30, 2025 Source for the quarter ended December 31, 2025: https://bit.ly/40hy6UE Source for the quarter ended September 30, 2025: https://bit.ly/4rOrIjE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million